GS-9190,
tegobuvir,
Tegobuvir,
1000787-75-6,
UNII-5NOK5X389M,
5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine,
5NOK5X389M,
GS-9190,
GS-333126,
W-204340,
5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-;5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-,
Tegobuvir [USAN:INN],
GS 9190,
GS 333126,
Tegobuvir (USAN/INN),
SCHEMBL496778,
CHEMBL1957287,
DTXSID80142917,
C25H14F7N5,
BCP28163,
4092AH,
MFCD18251457,
AKOS015949531,
API0013922,
CS-0672,
DB11852,
RP08100,
SB16972,
NCGC00378881-01,
HY-10544,
D09971,
W-5728,
J-516048,
5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine,
5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-,
Tegobuvir [USN:INN],
D09RVI,
A3864,
A11583,